Home / Market News / $XYL
benzinga Corporate Catalyst Impact 65/100 ● negative

RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $135

Oct 14, 2026, 2:19 PM UTC · Primary ticker $XYL

RBC Capital analyst Jeffrey Reive maintained an Outperform rating on Xylem but significantly lowered the price target from $164 to $135. This adjustment suggests a revised outlook on the company's valuation, potentially due to updated financial models or market conditions, despite the continued positive sentiment on its operational performance.

RBC Capital's decision to lower Xylem's price target from $164 to $135, while maintaining an 'Outperform' rating, indicates a recalibration of valuation expectations. This could be driven by various factors such as revised earnings forecasts, changes in discount rates, or a broader re-evaluation of the sector's growth prospects. For Xylem, this news presents a short-term negative sentiment as the reduced price target might signal slower growth or increased headwinds than previously anticipated. However, the maintained 'Outperform' rating suggests that the analyst still believes the stock will perform better than the broader market, implying that the underlying business fundamentals remain strong. Traders should consider this a moderate negative signal, potentially leading to some downward pressure on the stock in the short term, but the long-term outlook, according to RBC, remains positive.

$XYL negative price target lowered
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.